Latest Cancer News
• Rubicon Provides Genome Amplification For The Cancer Genome Atlas Project
Rubicon Genomics, Inc. announced an agreement with SAIC-Frederick to amplify DNA samples for The Cancer Atlas Genome Project. Rubicon Genomics was selected to amplify and standardize total genomic DNA from 3,000 tissue and blood samples from cancer patients.
• Indiana Health Industry Forum To Hold Cancer/Oncology Summit
Indiana institutions, companies and individuals with a common interest in cancer research, diagnosis and treatment will gather at a cancer/oncology summit Dec. 1-2 at the University Place Conference Center, IUPUI, in Indianapolis. "Emerging Trends and New Developments in Cancer Discovery, Diagno...
• Almost 60% Of Europeans Never Heard Of Neuropathic Pain (NeP), Which Affects ...
Alarmingly, nearly sixty per cent of Europeans have never heard of neuropathic pain (NeP), 1a a debilitating nerve condition that affects approximately 22 million people, 2,3 according to new surveys carried out amongst the general public and patients across Europe. NeP can often be a complication ...
• CEO Roundtable On Cancer Offers "Common Language" To Jump Start Cancer Clinic...
Potentially life-lengthening cancer therapies could enter clinical trials and ultimately reach cancer patients dramatically faster thanks to legal contract language created by the CEO Roundtable on Cancer, a nonprofit group of cancer-fighting CEOs. The group hopes to shorten the drug testing process...
• Long-Term Assessment Of Prostate Cancer Progression Free Survival
UroToday.com - In the online version of The Prostate, Dr. Robert W. Veltri and his colleagues from Johns Hopkins University reported on the correlation of molecular pathways and progression-free survival (PFS) in prostate cancer (CaP).
